| Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP JC McGrath, E Lilley British journal of pharmacology 172 (13), 3189-3193, 2015 | 1288 | 2015 |
| ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020 E Lilley, SC Stanford, DE Kendall, SPH Alexander, G Cirino, JR Docherty, ... British journal of pharmacology 177 (16), 3611, 2020 | 679 | 2020 |
| PREPARE: guidelines for planning animal research and testing AJ Smith, RE Clutton, E Lilley, KEA Hansen, T Brattelid Laboratory animals 52 (2), 135-141, 2018 | 433 | 2018 |
| Refinement of animal models of sepsis and septic shock E Lilley, R Armstrong, N Clark, P Gray, P Hawkins, K Mason, ... Shock 43 (4), 304-316, 2015 | 88 | 2015 |
| Applying refinement to the use of mice and rats in rheumatoid arthritis research P Hawkins, R Armstrong, T Boden, P Garside, K Knight, E Lilley, M Seed, ... Inflammopharmacology 23, 131-150, 2015 | 79 | 2015 |
| Developing a collaborative agenda for humanities and social scientific research on laboratory animal science and welfare GF Davies, BJ Greenhough, P Hobson-West, RGW Kirk, K Applebee, ... PLoS One 11 (7), e0158791, 2016 | 76 | 2016 |
| Sex: A change in our guidelines to authors to ensure that this is no longer an ignored experimental variable JR Docherty, SC Stanford, RA Panattieri, SPH Alexander, G Cirino, ... British Journal of Pharmacology 176 (21), 4081, 2019 | 62 | 2019 |
| Refining rodent models of spinal cord injury E Lilley, MR Andrews, EJ Bradbury, H Elliott, P Hawkins, RM Ichiyama, ... Experimental neurology 328, 113273, 2020 | 48 | 2020 |
| Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport RP Watson, E Lilley, M Panesar, G Bhalay, S Langridge, SS Tian, ... Neurogastroenterology & Motility 24 (1), 65-e12, 2012 | 48 | 2012 |
| Antioxidant protection of NO‐induced relaxations of the mouse anococcygeus against inhibition by superoxide anions, hydroquinone and carboxy‐PTIO E Lilley, A Gibson British journal of pharmacology 119 (2), 432-438, 1996 | 47 | 1996 |
| Optimization of 1,3,4-Benzotriazepine-Based CCK2 Antagonists to Obtain Potent, Orally Active Inhibitors of Gastrin-Mediated Gastric Acid Secretion IM McDonald, JW Black, IM Buck, DJ Dunstone, EP Griffin, EA Harper, ... Journal of medicinal chemistry 50 (13), 3101-3112, 2007 | 46 | 2007 |
| Superoxide anions, free-radical scavengers, and nitrergic neurotransmission A Gibson, E Lilley General Pharmacology: The Vascular System 28 (4), 489-493, 1997 | 45 | 1997 |
| 7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2, 3-dihydro-1H-pyrido [2, 3-d] pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a … MS Nash, P McIntyre, A Groarke, E Lilley, A Culshaw, A Hallett, ... Journal of Pharmacology and Experimental Therapeutics 342 (2), 389-398, 2012 | 44 | 2012 |
| Inhibition of relaxations to nitrergic stimulation of the mouse anococcygeus by duroquinone E Lilley, A Gibson British journal of pharmacology 116 (8), 3231-3236, 1995 | 43 | 1995 |
| Release of the antioxidants ascorbate and urate from a nitrergically‐innervated smooth muscle E Lilley, A Gibson British journal of pharmacology 122 (8), 1746-1752, 1997 | 38 | 1997 |
| The role of the three Rs in improving the planning and reproducibility of animal experiments AJ Smith, E Lilley Animals 9 (11), 975, 2019 | 30 | 2019 |
| Optimization of the in Vitro and in Vivo Properties of a Novel Series of 2,4,5-Trisubstituted Imidazoles as Potent Cholecystokinin-2 (CCK2) Antagonists IM Buck, JW Black, T Cooke, DJ Dunstone, JD Gaffen, EP Griffin, ... Journal of medicinal chemistry 48 (22), 6803-6812, 2005 | 28 | 2005 |
| Reducing suffering in experimental autoimmune encephalomyelitis (EAE) S Wolfensohn, P Hawkins, E Lilley, D Anthony, C Chambers, S Lane, ... Journal of pharmacological and toxicological methods 67 (3), 169-176, 2013 | 22 | 2013 |
| Rethinking animal models of sepsis–working towards improved clinical translation whilst integrating the 3Rs M Nandi, SK Jackson, D Macrae, M Shankar-Hari, JL Tremoleda, E Lilley Clinical Science 134 (13), 1715-1734, 2020 | 19 | 2020 |
| Reducing suffering in animal models and procedures involving seizures, convulsions and epilepsy S Wolfensohn, P Hawkins, E Lilley, D Anthony, C Chambers, S Lane, ... Journal of pharmacological and toxicological methods 67 (1), 9-15, 2013 | 19 | 2013 |
